JPH0542258B2 - - Google Patents
Info
- Publication number
- JPH0542258B2 JPH0542258B2 JP60191624A JP19162485A JPH0542258B2 JP H0542258 B2 JPH0542258 B2 JP H0542258B2 JP 60191624 A JP60191624 A JP 60191624A JP 19162485 A JP19162485 A JP 19162485A JP H0542258 B2 JPH0542258 B2 JP H0542258B2
- Authority
- JP
- Japan
- Prior art keywords
- chitosan
- aqueous solution
- culture
- washed
- culture substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000758 substrate Substances 0.000 claims description 40
- 229920001661 Chitosan Polymers 0.000 claims description 27
- 239000007864 aqueous solution Substances 0.000 claims description 16
- 238000004113 cell culture Methods 0.000 claims description 13
- 230000002378 acidificating effect Effects 0.000 claims description 7
- 238000004132 cross linking Methods 0.000 claims description 7
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- 239000003637 basic solution Substances 0.000 claims description 3
- 239000003431 cross linking reagent Substances 0.000 claims description 3
- 125000005442 diisocyanate group Chemical group 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 15
- 239000008363 phosphate buffer Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 230000006196 deacetylation Effects 0.000 description 7
- 238000003381 deacetylation reaction Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000000512 collagen gel Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- -1 diisocyanate compound Chemical class 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- FKTHNVSLHLHISI-UHFFFAOYSA-N 1,2-bis(isocyanatomethyl)benzene Chemical compound O=C=NCC1=CC=CC=C1CN=C=O FKTHNVSLHLHISI-UHFFFAOYSA-N 0.000 description 1
- ZXHZWRZAWJVPIC-UHFFFAOYSA-N 1,2-diisocyanatonaphthalene Chemical compound C1=CC=CC2=C(N=C=O)C(N=C=O)=CC=C21 ZXHZWRZAWJVPIC-UHFFFAOYSA-N 0.000 description 1
- ALQLPWJFHRMHIU-UHFFFAOYSA-N 1,4-diisocyanatobenzene Chemical compound O=C=NC1=CC=C(N=C=O)C=C1 ALQLPWJFHRMHIU-UHFFFAOYSA-N 0.000 description 1
- CDMDQYCEEKCBGR-UHFFFAOYSA-N 1,4-diisocyanatocyclohexane Chemical compound O=C=NC1CCC(N=C=O)CC1 CDMDQYCEEKCBGR-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 239000005058 Isophorone diisocyanate Substances 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- KXBFLNPZHXDQLV-UHFFFAOYSA-N [cyclohexyl(diisocyanato)methyl]cyclohexane Chemical compound C1CCCCC1C(N=C=O)(N=C=O)C1CCCCC1 KXBFLNPZHXDQLV-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009760 electrical discharge machining Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Description
本発明は、安全性、生体適合性、機械的強度に
優れた新規な細胞培養用基質に関するものであ
る。
The present invention relates to a novel cell culture substrate that has excellent safety, biocompatibility, and mechanical strength.
細胞培養用基質としては古くからガラス器具が
用いられている。それ以外としては、化学的エツ
チング又は放電加工をして濡れ特性を変化させた
プラスチツクシヤーレ、デキストランの架橋物に
電荷を導入したマイクロキヤリヤー、各種合成高
分子に電荷を導入したマイクロキヤリヤー及び化
学修飾させたコラーゲンゲル等が挙げられる。
これらの基質は何れも表面の濡れ特性、含水
率、イオン性相互作用やミクロドメイン構造等の
物理化学的パラメーターを変化させたり、生化学
的に特有な結合反応を用いて見出されたものであ
る。
しかし、プラスチツクシヤーレ等の材料では高
圧蒸気滅菌に耐えることが出来ず、又、デキスト
ラン架橋物、コラーゲンゲル等は機械的強度が低
い欠点がある。
又、合成高分子を用いたマイクロキヤリヤーの
製造には高度の技術を必要とし、この人工基質は
生体との馴染みの点で劣つている。
従つて、高圧蒸気滅菌に耐え、材料自体の溶出
物等に細胞毒のない強度的にも優れた基質の要望
が高いのが現状である。架橋処理したキトサン成
形物を細胞培養用基質に応用する考えは従来全く
なかつた。
Glassware has been used as a substrate for cell culture for a long time. Other examples include plastic shear whose wettability has been changed by chemical etching or electrical discharge machining, microcarriers with electrical charges introduced into cross-linked dextran, microcarriers with electrical charges introduced into various synthetic polymers, and Examples include chemically modified collagen gel. All of these substrates were discovered by changing physicochemical parameters such as surface wetting properties, water content, ionic interactions, and microdomain structure, or by using biochemically specific binding reactions. be. However, materials such as plastic shear cannot withstand high-pressure steam sterilization, and dextran crosslinked products, collagen gel, etc. have the disadvantage of low mechanical strength. Furthermore, the production of microcarriers using synthetic polymers requires sophisticated technology, and this artificial substrate is inferior in terms of compatibility with living organisms. Therefore, there is currently a high demand for a substrate that can withstand high-pressure steam sterilization and has excellent strength and is free from cytotoxic substances eluated from the material itself. Until now, there had been no idea of applying cross-linked chitosan molded products as substrates for cell culture.
本発明は上述した従来から知られている細胞培
養基質の諸欠点を解決するものである。
キトサンは天然の海老、蟹等の甲殻類に含まれ
ているキチンの脱アセチル化によつて得られる物
質であり、それ自体が生体由来であるので細胞毒
性が低く生体への馴染みも良好で、合成高分子物
質に見られる如き有毒な残存モノマーも含まれて
いないので安全性も極めて高い。又、キトサンは
適当な結晶構造を有するために機械的強度も高
く、高圧蒸気滅菌に対する耐性も高く、キトサン
は分子構造中にアミノ基を有しているため荷電の
導入、化学修飾による抗血栓性の付与、更には酵
素や蛋白の固定化の様な生化学的処理も容易であ
る性質がある。
従つて、本発明者等はキトサンの上記諸特徴に
注目して本発明をなしたものであつて、本発明に
より合成高分子にない優れた安全性、生体適合性
を有するキトサンを用いて、他の生体由来による
人工基質にない機械的強度の高い新規な細胞培養
用基質を得たものである。
The present invention solves the above-mentioned drawbacks of previously known cell culture substrates. Chitosan is a substance obtained by deacetylating chitin found in natural crustaceans such as shrimp and crabs, and since it is derived from living organisms, it has low cytotoxicity and is well compatible with living organisms. It is extremely safe as it does not contain any toxic residual monomers found in synthetic polymeric substances. In addition, chitosan has a suitable crystal structure, so it has high mechanical strength and high resistance to high-pressure steam sterilization.Chitosan has an amino group in its molecular structure, so it has antithrombotic properties by introducing a charge and chemical modification. It also has the property of being easy to apply biochemical treatments such as immobilization of enzymes and proteins. Therefore, the present inventors have created the present invention by paying attention to the above-mentioned characteristics of chitosan, and by using chitosan, which has excellent safety and biocompatibility that are not found in synthetic polymers, A novel cell culture substrate with high mechanical strength not found in other biologically derived artificial substrates has been obtained.
本発明の細胞培養用基質は、キトサンを原料と
して、これを酸性水溶液中に溶解し、塩基性溶液
中で膜状、繊維状、球状体等に成形し、架橋剤で
架橋処理することにより得られる。
使用するキトサンは特に限定はされないが、平
均分子量が10000〜230000の低分子量キトサンを
用いることが好ましい。キトサンは、酢酸、ジク
ロル酢酸、蟻酸等の単独、若しくは混合物の水溶
液に溶解する。キトサン酸性水溶液の濃度は取扱
いに適した範囲で任意に選択出来、該キトサン酸
性水溶液は水酸化ナトリウム、水酸化カリウム、
炭酸ナトリウム、炭酸カリウム、アンモニア、エ
チレンジアミン等のアルカリ性物質を含む塩基性
水溶液中で凝固せしめる。塩基性水溶液には、メ
タノール、エタノール等の極性を有するアルコー
ル類を加えて使用することもできる。
本発明による細胞培養用基質は、膜状、繊維
状、球状体等任意の形状とすることができる。膜
状とする場合はキトサン酸性水溶液を固体上に塗
布後塩基性水溶液中に浸漬させる、膜状に塩基性
溶液中に押出し成形する等の方法がとられ、又、
繊維状、球状とする場合は、キトサン酸性水溶液
を吐出口より圧力下に塩基性水溶液よりなる凝固
浴中に連続的に又は一定量ずつそれぞれ供給、凝
固せしめることによつて得られる。
上記のようにして得られたキトサン成形物は、
有機ジイソシアネート化合物、エピハロヒドリ
ン、グルタールアルデヒドや有機ハライドで架橋
処理を行う。架橋処理を行うことによつて、キト
サン成形物は機械的強度が増加し取扱いに便利な
ものとなる。
有機ジイソシアネート化合物を用いて架橋反応
を行う場合は、極性溶媒中で反応を行う。極性溶
媒としては、メタノール、エタノール、イソプロ
ピルアルコール等のアルコール類、アセトン、メ
チルエチルケトン等のケトン類、ジメチルホルム
アミド、ジメチルアセトアミド等のアミド類が使
用できる。又、有機ジイソシアネート化合物とし
ては、例えば4,4′−ジフエニルメタンジイソシ
アネート、1,4−フエニレンジイソシアネー
ト、2,4−トリレンジイソシアネート、ナフタ
レンジイソシアネート、1,4−シクロヘキサン
ジイソシアネート、4,4′−ジシクロヘキシルメ
タンジイソシアネート、キシリレンジイソシアネ
ート、イソフオロンジイソシアネート、ヘキサメ
チレンジイソシアネート等が挙げられる。
本発明による細胞培養用基質は、インターフエ
ロン、腫瘍抗原、ウロキナーゼ、インシユリン、
モノクローナル抗体等を分離、精製する際の細胞
大量培養用の基質としてのみならず細胞を生着さ
せ、生体本来の能力を生かした人工臓器として注
目されているハイブリツド型人工臓器としても応
用できる。
The cell culture substrate of the present invention can be obtained by using chitosan as a raw material, dissolving it in an acidic aqueous solution, shaping it into a membrane, fiber, sphere, etc. in a basic solution, and crosslinking it with a crosslinking agent. It will be done. Although the chitosan used is not particularly limited, it is preferable to use a low molecular weight chitosan having an average molecular weight of 10,000 to 230,000. Chitosan is dissolved in an aqueous solution of acetic acid, dichloroacetic acid, formic acid, etc. alone or in a mixture. The concentration of the chitosan acidic aqueous solution can be arbitrarily selected within a range suitable for handling, and the chitosan acidic aqueous solution contains sodium hydroxide, potassium hydroxide,
Coagulate in a basic aqueous solution containing alkaline substances such as sodium carbonate, potassium carbonate, ammonia, and ethylenediamine. A polar alcohol such as methanol or ethanol may be added to the basic aqueous solution. The cell culture substrate according to the present invention can have any shape such as membrane, fiber, or spherical shape. In order to form a film, methods such as applying an acidic chitosan aqueous solution onto a solid and immersing it in a basic aqueous solution, or extruding it into a film into a basic solution, etc. are used.
In the case of fibrous or spherical shapes, the chitosan acidic aqueous solution is supplied under pressure from a discharge port into a coagulation bath consisting of a basic aqueous solution, either continuously or in a fixed amount, and is obtained by coagulating the chitosan acidic aqueous solution. The chitosan molded product obtained as above is
Crosslinking treatment is performed using an organic diisocyanate compound, epihalohydrin, glutaraldehyde, or organic halide. By crosslinking, the chitosan molded product has increased mechanical strength and becomes convenient to handle. When performing a crosslinking reaction using an organic diisocyanate compound, the reaction is performed in a polar solvent. As the polar solvent, alcohols such as methanol, ethanol and isopropyl alcohol, ketones such as acetone and methyl ethyl ketone, and amides such as dimethylformamide and dimethylacetamide can be used. Examples of organic diisocyanate compounds include 4,4'-diphenylmethane diisocyanate, 1,4-phenylene diisocyanate, 2,4-tolylene diisocyanate, naphthalene diisocyanate, 1,4-cyclohexane diisocyanate, 4,4'- Examples include dicyclohexylmethane diisocyanate, xylylene diisocyanate, isophorone diisocyanate, hexamethylene diisocyanate, and the like. The cell culture substrate according to the present invention includes interferon, tumor antigen, urokinase, insulin,
It can be used not only as a substrate for mass culture of cells when separating and purifying monoclonal antibodies, etc., but also as a hybrid artificial organ, which is attracting attention as an artificial organ that allows cells to engraft and makes use of the natural abilities of living organisms.
次に実施例を挙げて、本発明を説明する。
実施例における細胞懸濁液、培養及び計数方法
は次の通りである。
(1) 培養液としてイーグル最少必須培地に10%ウ
シ胎児血清を加えたものを用いた。
(2) 細胞としてはマウス結合組織由来繊維芽細胞
であるL929、アフリカミドリザル腎臓由来繊
維芽細胞であるVeroを用いた。
(3) (1)の培養液に1.0×105cells/mlになるように
(2)の各細胞を懸濁させた。
(4) 各シヤーレに細胞懸濁液5mlを分注し37℃、
CO25%雰囲気下で1、2、4日培養後の細胞
数をそれぞれ計測した。
(5) 計数方法は浮遊細胞(生着せず浮遊している
細胞)と培養液を燐酸緩衝液で除去し、生着細
胞をトリプシン−EDTA溶液処理で剥離し、
しかる後該液を700rpm、6分間遠心分離し、
トリプシン−EDTA溶液等を除去後、沈澱し
た細胞を燐酸緩衝液2ml中に懸濁し、血球計算
盤により計測した。
◇実施例 1
分子量200000で脱アセチル化度80%と95%のキ
トサンを0.5%酢酸水溶液とし、この2mlをそれ
ぞれ直径60mmのガラスシヤーレの底面に均一に注
入し、5%アンモニア水で中和し成膜して純水で
水洗後湯洗し40℃で乾燥した。このシヤーレ上の
膜に対し5%エピクロロヒドリンのエタノール溶
液を10ml注加し40℃で4時間静置し、エタノール
で3回洗浄後純水で水洗をし更に80℃で湯洗を1
時間行い、121℃で20分間高圧蒸気滅菌し、無菌
下で燐酸緩衝液で洗浄し試料番号1、2の培養用
基質を得た。又、分子量200000と43000で脱アセ
チル化度95%のキトサンを用いて上述の如くシヤ
ーレ上に膜を作り、2.5%グルタールアルデヒド
の純水溶液10mlを注加し、室温で2時間静置し、
純水で水洗し80℃の湯で1時間湯洗を行い、121
℃で20分間高圧蒸気滅菌し、無菌下で燐酸緩衝液
で洗浄し試料番号3、4の培養用基質を得た。
又、分子量200000で脱アセチル化度80%と95%の
キトサンを用いて上述の如くシヤーレ上に膜を作
り、5%のヘキサメチレンジイソシアネート
(HDI)のジメチルホルムアミド溶液10mlを注加
し室温で1.5時間静置しジメチルホルムアミドで
3回洗浄後純水で洗浄後80℃の湯水で30分間湯洗
を行い、121℃で20分間高圧蒸気滅菌し無菌下で
燐酸緩衝液で洗浄し、試料番号5、6の培養用基
質を得た。又、分子量43000と200000で脱アセチ
ル化度95%のキトサンを用いて上述の如くシヤー
レ上に膜を作り、1%の4,4′ジフエニルメタン
ジイソシアネート(MDI)のジメチルホルムア
ミド溶液10mlを注加し室温で1時間静置し、ジメ
チルホルムアミドで3回洗浄後純水で水洗し、80
℃の湯水で30分間湯洗した。これを121℃で20分
間高圧蒸気滅菌し無菌下で燐酸緩衝液で洗浄し、
試料番号7、8の培養用基質を得た。
又、分子量43000と200000で脱アセチル化度95
%のキトサンを用いて上述の如くシヤーレ上に膜
を作り、5%塩化シアヌルのジメチルホルムアミ
ド溶液10mlを注加し、80℃で2時間静置しジメチ
ルホルムアミドで3回洗浄後、純水で水洗して80
℃の湯水で1時間湯洗を行い、121℃で20分間高
圧蒸気滅菌し、無菌下で燐酸緩衝液で洗浄して試
料番号9、10の培養用基質を得た。
これら試料番号1から試料番号10について、こ
れら基質に対し、細胞L929を培養した。1、2、
4日後の細胞数を従来から使用されているガラス
シヤーレを培養基質として使用した比較例1と共
に第1表に示す。本発明による培養基質は、架橋
反応させることにより強度が増加して取扱いが容
易であると共に、培養基質としての性能も優れた
ものであつた。
Next, the present invention will be explained with reference to Examples. Cell suspension, culture and counting methods in Examples are as follows. (1) Eagle's minimum essential medium supplemented with 10% fetal bovine serum was used as the culture medium. (2) The cells used were L929, a mouse connective tissue-derived fibroblast, and Vero, an African green monkey kidney-derived fibroblast. (3) Add 1.0×10 5 cells/ml to the culture solution in (1).
Each cell in (2) was suspended. (4) Dispense 5 ml of cell suspension into each dish and heat at 37°C.
The number of cells was counted after culturing for 1, 2, and 4 days in an atmosphere of 5% CO 2 . (5) The counting method is to remove floating cells (cells that are floating without engrafting) and the culture medium with a phosphate buffer, detach the engrafted cells with a trypsin-EDTA solution treatment, and
After that, the liquid was centrifuged at 700 rpm for 6 minutes,
After removing the trypsin-EDTA solution, etc., the precipitated cells were suspended in 2 ml of phosphate buffer and counted using a hemocytometer. ◇Example 1 Chitosan with a molecular weight of 200,000 and a degree of deacetylation of 80% and 95% was made into a 0.5% acetic acid aqueous solution, and 2 ml of this was uniformly injected into the bottom of a glass shear dish with a diameter of 60 mm, and neutralized with 5% ammonia water to form a solution. The membrane was washed with pure water, hot water, and dried at 40°C. 10 ml of 5% epichlorohydrin in ethanol was poured onto the film on the shear plate, left to stand at 40°C for 4 hours, washed 3 times with ethanol, then rinsed with pure water, and then washed once with hot water at 80°C.
The samples were sterilized using high-pressure steam at 121°C for 20 minutes, and washed with phosphate buffer under aseptic conditions to obtain culture substrates of sample numbers 1 and 2. In addition, a film was made on Shearle as described above using chitosan with a molecular weight of 200,000 and 43,000 and a degree of deacetylation of 95%, and 10 ml of a pure aqueous solution of 2.5% glutaraldehyde was poured into it, and the film was allowed to stand at room temperature for 2 hours.
Rinse with pure water, then rinse with hot water at 80℃ for 1 hour.
The samples were sterilized with high-pressure steam at ℃ for 20 minutes and washed with phosphate buffer under aseptic conditions to obtain culture substrates of sample numbers 3 and 4.
In addition, a film was made on Shearle as described above using chitosan with a molecular weight of 200,000 and a degree of deacetylation of 80% and 95%, and 10 ml of a 5% hexamethylene diisocyanate (HDI) solution in dimethylformamide was added to the film and the mixture was heated at room temperature for 1.5 min. Let it stand for an hour, wash it three times with dimethylformamide, wash it with pure water, wash it with hot water at 80℃ for 30 minutes, autoclave it at 121℃ for 20 minutes, wash it with phosphate buffer under aseptic conditions, and sample number 5. , 6 culture substrates were obtained. In addition, a film was made on Shearle as described above using chitosan with a molecular weight of 43,000 and 200,000 and a degree of deacetylation of 95%, and 10 ml of a 1% solution of 4,4' diphenylmethane diisocyanate (MDI) in dimethylformamide was poured. Leave it at room temperature for 1 hour, wash it 3 times with dimethylformamide, and then with pure water.
Washed in hot water at ℃ for 30 minutes. This was autoclaved at 121°C for 20 minutes, washed with phosphate buffer under aseptic conditions,
Culture substrates of sample numbers 7 and 8 were obtained. In addition, the degree of deacetylation is 95 with a molecular weight of 43,000 and 200,000.
% of chitosan was used as described above, 10 ml of 5% cyanuric chloride in dimethylformamide was poured into the film, and the film was left to stand at 80°C for 2 hours, washed three times with dimethylformamide, and then washed with pure water. and 80
The samples were washed with hot water at 121°C for 1 hour, sterilized with high-pressure steam at 121°C for 20 minutes, and washed with phosphate buffer under aseptic conditions to obtain culture substrates of sample numbers 9 and 10. For these sample numbers 1 to 10, cells L929 were cultured on these substrates. 1, 2,
The number of cells after 4 days is shown in Table 1 together with Comparative Example 1 in which conventionally used glass shears were used as the culture substrate. The culture substrate according to the present invention had increased strength due to the crosslinking reaction, was easy to handle, and had excellent performance as a culture substrate.
【表】
又、分子量200000で脱アセチル化度95%の上記
試料番号4及び8に用いた培養用基質を使用し、
試料番号11、12として細胞Veroを培養した結果
をガラスシヤーレを培養基質とした比較例2の細
胞数と共に第2表に示す。架橋反応を行つたキト
サン培養基質は、細胞L929の場合と同様に優れ
た培養基質としての性能を示した。[Table] Also, using the culture substrate used for sample numbers 4 and 8 above with a molecular weight of 200,000 and a degree of deacetylation of 95%,
The results of culturing Vero cells as sample numbers 11 and 12 are shown in Table 2 together with the cell counts of Comparative Example 2 using glass shear as the culture substrate. The chitosan culture substrate subjected to the crosslinking reaction showed excellent performance as a culture substrate, as in the case of cell L929.
【表】
◇実施例 2
平均分子量42000で脱アセチル化度80%のキト
サンの5%酢酸水溶液を、10%NaOH、30%
CH3OHと水からなる塩基性水溶液中にノズル孔
径0.24mmのノズルよりN2圧力2Kg/cm2で落下さ
せ球状に成形した後、この球状物を洗液が中性に
なる迄水洗し、粒度が42〜80メツシユの球状基質
を得た。この球状物100mlを取り出し、ジメチル
ホルムアミド置換を4回行つた後、10%4,4′ジ
フエニルメタンジイソシアネート(MDI)100ml
を注加し室温で1時間撹拌した。その後ジメチル
ホルムアミドで3回置換後水洗し80℃湯水で1時
間湯洗し、燐酸緩衝液で置換後121℃で20分間高
圧蒸気滅菌し、無菌下で燐酸緩衝液で洗浄し、試
料番号17の培養用基質を得た。
又、別に球状物100mlに対し2.5%グルタールア
ルデヒド100mlを注加し、室温で2時間撹拌後純
水で水洗し80℃湯水で1時間湯洗した。これを燐
酸緩衝液で置換後121℃で20分間高圧蒸気滅菌し、
無菌下で燐酸緩衝液で洗浄し試料番号18の培養用
基質とした。これら試料番号13、14の培養基質を
シヤーレに所定量入れて細胞L929を培養した。
該培養の結果を比較例3として市販の培養基質
(Cytodex type、スウエーデンPharmacia社
製)を用いた結果と共に第3表に示した。これら
の結果から、球状体のキトサン基質も優れた培養
基質としての性能を有することが判明した。[Table] ◇Example 2 A 5% acetic acid aqueous solution of chitosan with an average molecular weight of 42,000 and a degree of deacetylation of 80% was mixed with 10% NaOH and 30%
After forming into a sphere by dropping N 2 into a basic aqueous solution consisting of CH 3 OH and water through a nozzle with a nozzle diameter of 0.24 mm at a pressure of 2 kg/cm 2 , the spherical object was washed with water until the washing liquid became neutral. Spherical substrates with a particle size of 42-80 mesh were obtained. Take out 100 ml of this spherical material, perform dimethylformamide substitution four times, and then add 100 ml of 10% 4,4' diphenylmethane diisocyanate (MDI).
was added and stirred at room temperature for 1 hour. After that, after replacing with dimethylformamide three times, washing with water, washing with hot water at 80℃ for 1 hour, replacing with phosphate buffer, autoclaving at 121℃ for 20 minutes, washing with phosphate buffer under aseptic conditions, and using sample number 17. A culture substrate was obtained. Separately, 100 ml of 2.5% glutaraldehyde was added to 100 ml of the spherical material, stirred at room temperature for 2 hours, washed with pure water, and then washed with hot water at 80° C. for 1 hour. After replacing this with phosphate buffer, it was sterilized with high pressure steam at 121℃ for 20 minutes.
It was washed with phosphate buffer under sterile conditions and used as a culture substrate for sample number 18. A predetermined amount of the culture substrates of Sample Nos. 13 and 14 were placed in a shear dish, and cells L929 were cultured.
The results of this culture are shown in Table 3 together with the results obtained using a commercially available culture substrate (Cytodex type, manufactured by Pharmacia, Sweden) as Comparative Example 3. These results revealed that the spherical chitosan substrate also has excellent performance as a culture substrate.
【表】【table】
本発明の細胞培養用基質は、上記実施例の記載
から明らかなように高圧蒸気滅菌が可能であり、
成形後のキトサン培養基質を架橋処理してあるの
で、機械的強度が増加し、取扱いに便利なものと
することができる。本発明による細胞培養用基質
は、従来用いられている基質と全く同様の細胞培
養についての優れた性能を有し、本発明によつ
て、細胞の増殖、機械的強度、高圧蒸気滅菌耐性
及び低毒性等に於いて極めて有用にして安全な基
質が提供されるものである。
As is clear from the description of the above examples, the cell culture substrate of the present invention can be sterilized with high pressure steam,
Since the molded chitosan culture substrate is cross-linked, its mechanical strength is increased and it can be easily handled. The cell culture substrate according to the present invention has excellent performance for cell culture, which is exactly the same as that of conventionally used substrates. This provides a very useful and safe substrate in terms of toxicity and the like.
Claims (1)
性溶液中で再生成形し、次いで架橋剤で架橋処理
をしてなることを特徴とする細胞培養用基質。 2 該架橋処理を行う架橋剤が、有機ジイソシア
ネート、エピハロヒドリン、グルタールアルデヒ
ド及び有機ハライドの何れかである特許請求の範
囲第1項に記載の細胞培養用基質。[Scope of Claims] 1. A substrate for cell culture, characterized in that chitosan is dissolved in an acidic aqueous solution, re-molded in a basic solution, and then cross-linked with a cross-linking agent. 2. The cell culture substrate according to claim 1, wherein the crosslinking agent that performs the crosslinking treatment is any one of organic diisocyanate, epihalohydrin, glutaraldehyde, and organic halide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60191624A JPS6251982A (en) | 1985-08-30 | 1985-08-30 | Substrate for cultivating cell |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60191624A JPS6251982A (en) | 1985-08-30 | 1985-08-30 | Substrate for cultivating cell |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6251982A JPS6251982A (en) | 1987-03-06 |
JPH0542258B2 true JPH0542258B2 (en) | 1993-06-28 |
Family
ID=16277736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60191624A Granted JPS6251982A (en) | 1985-08-30 | 1985-08-30 | Substrate for cultivating cell |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6251982A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4789601A (en) * | 1987-05-04 | 1988-12-06 | Banes Albert J | Biocompatible polyorganosiloxane composition for cell culture apparatus |
JPH02135134A (en) * | 1988-11-16 | 1990-05-24 | Katokichi:Kk | Membrane for separating water-alcohol mixed liquid |
DE10117234A1 (en) * | 2001-04-06 | 2002-10-10 | Alvito Biotechnologie Gmbh | Porous and non-porous matrices based on chitosan and hydroxycarboxylic acids |
US20050238702A1 (en) * | 2002-04-23 | 2005-10-27 | Netech, Inc | Medical composition containing photocrosslinkable chitosan derivative |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6062979A (en) * | 1983-08-15 | 1985-04-11 | ウイリアム グラハム マレツト | Changing of growth of tissue culture |
-
1985
- 1985-08-30 JP JP60191624A patent/JPS6251982A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6062979A (en) * | 1983-08-15 | 1985-04-11 | ウイリアム グラハム マレツト | Changing of growth of tissue culture |
Also Published As
Publication number | Publication date |
---|---|
JPS6251982A (en) | 1987-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Felse et al. | Studies on applications of chitin and its derivatives | |
CN108047465B (en) | Methacrylate gelatin/chitosan interpenetrating network hydrogel, preparation method and application | |
Kang et al. | One‐step multipurpose surface functionalization by adhesive catecholamine | |
JP2520858B2 (en) | Collagen treatment method for facilitating crosslinking of collagen | |
Cheng et al. | Studies on nerve cell affinity of biodegradable modified chitosan films | |
JP4187917B2 (en) | Method for producing glycosaminoglycan-collagen complex for tissue regeneration matrix | |
CN112778543B (en) | Preparation method and application of crosslinked hydrogel for muscle stem cell culture | |
da Silva et al. | Alginate and sericin: environmental and pharmaceutical applications | |
Wang et al. | Improvement in physical and biological properties of chitosan/soy protein films by surface grafted heparin | |
JP2008291258A (en) | Water soluble crosslinking agent for elastin | |
CN110152055B (en) | Functional drug sustained-release medical dressing constructed by alginic acid aminated derivative/bacterial cellulose nanocrystalline composite gel | |
JP2023554582A (en) | Method for preparing cross-linked hydrogel for culturing muscle stem cells and its use | |
JPH04275346A (en) | Compatibel mixture containing chitosan | |
JPH02109570A (en) | Silkfibroin-containing molding | |
CN114344555A (en) | Multifunctional hemostatic material and preparation method thereof | |
JPH0542258B2 (en) | ||
CN1119172C (en) | Chitosan/gelatin network modification on surface of aliphatic polyester | |
CN107216496A (en) | A kind of chitosan material of controllable amino content and preparation method thereof | |
JPS6341541A (en) | Molded high polymer article having chitosan component on surface | |
JP2628536B2 (en) | Cell culture substrate | |
JP3311074B2 (en) | Cell culture substrate | |
CN115010958A (en) | Hydrogel for promoting wound healing and preparation method and application thereof | |
CN108546338A (en) | A kind of natural silk compound bio glass material preparation method | |
EP0318286A2 (en) | A substratum for cell culture and its production and use | |
CN109384943B (en) | Preparation method of antibacterial high-strength chitosan/heparin sodium ion compound self-assembled hydrogel membrane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |